{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:04:05Z","timestamp":1793639045389,"version":"4.5.1"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Science and Technology planning project of Tianjin","doi-asserted-by":"crossref","award":["20JCYBJC01000"],"award-info":[{"award-number":["20JCYBJC01000"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100019065","name":"Science and Technology planning project of Tianjin","doi-asserted-by":"crossref","award":["20JCYBJC01000"],"award-info":[{"award-number":["20JCYBJC01000"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00011-025-02043-2","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:37:53Z","timestamp":1745905073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Advances in anti-inflammatory treatment of sepsis-associated acute respiratory distress syndrome"],"prefix":"10.1007","volume":"74","author":[{"given":"Nana","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hewei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"2043_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"CS Mervyn Singer","year":"2016","unstructured":"Mervyn Singer CS, Deutschman CW, Seymour, et al. The third international consensus definitions for Sepsis and septic shock (Sepsis-3). JAMA. 2016;315:801\u201310. https:\/\/doi.org\/10.1001\/jama.2016.0287.","journal-title":"JAMA"},{"key":"2043_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","volume":"395","author":"E Kristina","year":"2020","unstructured":"Kristina E, Rudd SC, Johnson KM, Agesa, et al. Global, regional, and National sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study. Lancet (London England). 2020;395:200\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(19)32989-7.","journal-title":"Lancet (London England)"},{"key":"2043_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-018-5203-z","author":"L Weng","year":"2018","unstructured":"Weng L, Zeng Xy, Yin P, et al. Sepsis-related mortality in China: a descriptive analysis. Intensive Care Med. 2018. https:\/\/doi.org\/10.1007\/s00134-018-5203-z. 44:.","journal-title":"Intensive Care Med"},{"key":"2043_CR4","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","volume":"48","author":"H Jianfeng Xie","year":"2020","unstructured":"Jianfeng Xie H, Wang Y, Kang, et al. The epidemiology of Sepsis in Chinese ICUs: A National Cross-Sectional survey. Crit Care Med. 2020;48:e209. https:\/\/doi.org\/10.1097\/CCM.0000000000004155.","journal-title":"Crit Care Med"},{"key":"2043_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","volume":"39","author":"G Benjamin","year":"2017","unstructured":"Benjamin G, Chousterman FK, Swirski, Georg F, Weber. Cytokine storm and sepsis disease pathogenesis. Semin Immunopathol. 2017;39:517\u201328. https:\/\/doi.org\/10.1007\/s00281-017-0639-8.","journal-title":"Semin Immunopathol"},{"key":"2043_CR6","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(22)01485-4","volume":"400","author":"DJ Lieuwe","year":"2022","unstructured":"Lieuwe DJ, Bos, Lorraine B, Ware. Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes. Lancet (London England). 2022;400:1145\u201356. https:\/\/doi.org\/10.1016\/S0140-6736(22)01485-4.","journal-title":"Lancet (London England)"},{"key":"2043_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"JG Giacomo Bellani","year":"2016","unstructured":"Giacomo Bellani JG, Laffey, T\u00e0i P, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries. JAMA. 2016;315:788\u2013800. https:\/\/doi.org\/10.1001\/jama.2016.0291.","journal-title":"JAMA"},{"key":"2043_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1378\/chest.09-2933","volume":"138","author":"MN Chau-Chyun Sheu","year":"2010","unstructured":"Chau-Chyun Sheu MN, Gong R, Zhai, et al. Clinical characteristics and outcomes of sepsis-related vs non-sepsis-related ARDS. Chest. 2010;138:559\u201367. https:\/\/doi.org\/10.1378\/chest.09-2933.","journal-title":"Chest"},{"key":"2043_CR9","doi-asserted-by":"publisher","first-page":"112548","DOI":"10.1016\/j.intimp.2024.112548","volume":"138","author":"Q Zhize Yuan","year":"2024","unstructured":"Zhize Yuan Q, Wang Y, Tan, et al. Methylprednisolone alleviates lung injury in sepsis by regulating miR-151-5p\/USP38 pathway. Int Immunopharmacol. 2024;138:112548. https:\/\/doi.org\/10.1016\/j.intimp.2024.112548.","journal-title":"Int Immunopharmacol"},{"key":"2043_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12967-017-1284-7","volume":"15","author":"G-W Tu","year":"2017","unstructured":"Tu G-W, Shi Y, Zheng Y-J, et al. Glucocorticoid attenuates acute lung injury through induction of type 2 macrophage. J Transl Med. 2017;15:181. https:\/\/doi.org\/10.1186\/s12967-017-1284-7.","journal-title":"J Transl Med"},{"key":"2043_CR11","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3892\/etm.2018.6926","volume":"17","author":"Z Mengting Qin","year":"2019","unstructured":"Mengting Qin Z Qiu. Changes in TNF-\u03b1, IL-6, IL-10 and VEGF in rats with ARDS and the effects of dexamethasone. Exp Ther Med. 2019;17:383\u20137. https:\/\/doi.org\/10.3892\/etm.2018.6926.","journal-title":"Exp Ther Med"},{"key":"2043_CR12","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1001\/jama.2020.17021","volume":"324","author":"M Bruno","year":"2020","unstructured":"Bruno M, Tomazini IS, Maia AB, Cavalcanti, et al. Effect of dexamethasone on days alive and Ventilator-Free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. 2020;324:1307. https:\/\/doi.org\/10.1001\/jama.2020.17021.","journal-title":"JAMA"},{"key":"2043_CR13","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","volume":"8","author":"C Jes\u00fas Villar","year":"2020","unstructured":"Jes\u00fas Villar C, Ferrando D, Mart\u00ednez, et al. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial. Lancet Respiratory Med. 2020;8:267\u201376. https:\/\/doi.org\/10.1016\/S2213-2600(19)30417-5.","journal-title":"Lancet Respiratory Med"},{"key":"2043_CR14","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","volume":"388","author":"F Pierre-Fran\u00e7ois Dequin","year":"2023","unstructured":"Pierre-Fran\u00e7ois Dequin F, Meziani J-P, Quenot, et al. Hydrocortisone in severe Community-Acquired pneumonia. N Engl J Med. 2023;388:1931\u201341. https:\/\/doi.org\/10.1056\/NEJMoa2215145.","journal-title":"N Engl J Med"},{"key":"2043_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/ALN.0000000000000907","volume":"124","author":"Y Vito Fanelli","year":"2016","unstructured":"Vito Fanelli Y, Morita P, Cappello, et al. Neuromuscular blocking agent cisatracurium attenuates lung injury by Inhibition of nicotinic acetylcholine Receptor-\u03b11. Anesthesiology. 2016;124:132\u201340. https:\/\/doi.org\/10.1097\/ALN.0000000000000907.","journal-title":"Anesthesiology"},{"key":"2043_CR16","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s13054-018-1974-4","volume":"22","author":"D Peter","year":"2018","unstructured":"Peter D, Sottile D, Albers MM, Moss. Neuromuscular Blockade is associated with the Attenuation of biomarkers of epithelial and endothelial injury in patients with moderate-to-severe acute respiratory distress syndrome. Crit Care (London England). 2018;22:63. https:\/\/doi.org\/10.1186\/s13054-018-1974-4.","journal-title":"Crit Care (London England)"},{"key":"2043_CR17","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1097\/01.CCM.0000239435.87433.0D","volume":"34","author":"J-M Forel","year":"2006","unstructured":"Forel J-M, Roch A, Val\u00e9rie Marin, et al. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Crit Care Med. 2006;34:2749\u201357. https:\/\/doi.org\/10.1097\/01.CCM.0000239435.87433.0D.","journal-title":"Crit Care Med"},{"key":"2043_CR18","doi-asserted-by":"publisher","first-page":"828","DOI":"10.4149\/BLL_2022_132","volume":"123","author":"B Nur Canbolat","year":"2022","unstructured":"Nur Canbolat B, Ozkul IH, Sever, et al. Vitamins C and E protect from sepsis-induced lung damage in rat and CT correlation. Bratisl Lek Listy. 2022;123:828\u201332. https:\/\/doi.org\/10.4149\/BLL_2022_132.","journal-title":"Bratisl Lek Listy"},{"key":"2043_CR19","doi-asserted-by":"publisher","first-page":"L20","DOI":"10.1152\/ajplung.00300.2011","volume":"303","author":"J Bernard","year":"2012","unstructured":"Bernard J, Fisher D, Kraskauskas EJ, Martin, et al. Mechanisms of Attenuation of abdominal sepsis induced acute lung injury by ascorbic acid. Am J Physiol Lung Cell Mol Physiol. 2012;303:L20\u201332. https:\/\/doi.org\/10.1152\/ajplung.00300.2011.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2043_CR20","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.3390\/nu5083131","volume":"5","author":"M Bassem","year":"2013","unstructured":"Bassem M, Mohammed BJ, Fisher D, Kraskauskas, et al. Vitamin C: a novel regulator of neutrophil extracellular trap formation. Nutrients. 2013;5:3131\u201351. https:\/\/doi.org\/10.3390\/nu5083131.","journal-title":"Nutrients"},{"key":"2043_CR21","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.3390\/nu14204415","volume":"14","author":"MG Xian Qiao","year":"2022","unstructured":"Xian Qiao MG, Kashiouris ML\u2019Heureux, et al. Biological effects of intravenous vitamin C on neutrophil extracellular traps and the endothelial glycocalyx in patients with Sepsis-Induced ARDS. Nutrients. 2022;14:4415. https:\/\/doi.org\/10.3390\/nu14204415.","journal-title":"Nutrients"},{"key":"2043_CR22","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1001\/jama.2019.11825","volume":"322","author":"A Alpha","year":"2019","unstructured":"Alpha A, Fowler JD, Truwit R, Duncan Hite, et al. Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with Sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial. JAMA. 2019;322:1261\u201370. https:\/\/doi.org\/10.1001\/jama.2019.11825.","journal-title":"JAMA"},{"key":"2043_CR23","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.18632\/aging.202557","volume":"13","author":"D Gao","year":"2021","unstructured":"Gao D, Xu M, Wang G, et al. The efficiency and safety of high-dose vitamin C in patients with COVID-19: a retrospective cohort study. Aging. 2021;13:7020\u201334. https:\/\/doi.org\/10.18632\/aging.202557.","journal-title":"Aging"},{"key":"2043_CR24","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.chest.2016.11.036","volume":"151","author":"E Paul","year":"2017","unstructured":"Paul E, Marik V, Khangoora R, Rivera, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe Sepsis and septic shock: A retrospective Before-After study. Chest. 2017;151:1229\u201338. https:\/\/doi.org\/10.1016\/j.chest.2016.11.036.","journal-title":"Chest"},{"key":"2043_CR25","doi-asserted-by":"publisher","first-page":"116621","DOI":"10.1016\/j.biopha.2024.116621","volume":"175","author":"Y Fei","year":"2024","unstructured":"Fei Y, Huang X, Ning F, et al. NETs induce ferroptosis of endothelial cells in LPS-ALI through SDC-1\/HS and downstream pathways. Biomedecine Pharmacotherapie. 2024;175:116621. https:\/\/doi.org\/10.1016\/j.biopha.2024.116621.","journal-title":"Biomedecine Pharmacotherapie"},{"key":"2043_CR26","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.ajpath.2019.05.002","volume":"189","author":"H Kodai Suzuki","year":"2019","unstructured":"Kodai Suzuki H, Okada G, Takemura, et al. Neutrophil elastase damages the pulmonary endothelial glycocalyx in Lipopolysaccharide-Induced experimental endotoxemia. Am J Pathol. 2019;189:1526\u201335. https:\/\/doi.org\/10.1016\/j.ajpath.2019.05.002.","journal-title":"Am J Pathol"},{"key":"2043_CR27","doi-asserted-by":"publisher","first-page":"108080","DOI":"10.1016\/j.compbiomed.2024.108080","volume":"170","author":"G Jiajia Ren","year":"2024","unstructured":"Jiajia Ren G, Deng R, Li, et al. Possible Pharmacological targets and mechanisms of Sivelestat in protecting acute lung injury. Comput Biol Med. 2024;170:108080. https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108080.","journal-title":"Comput Biol Med"},{"key":"2043_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S36436","volume":"6","author":"S Yoshiaki Tsuboko","year":"2012","unstructured":"Yoshiaki Tsuboko S, Takeda S, Mii, et al. Clinical evaluation of Sivelestat for acute lung injury\/acute respiratory distress syndrome following surgery for abdominal sepsis. Drug Des Devel Ther. 2012;6:273\u20138. https:\/\/doi.org\/10.2147\/DDDT.S36436.","journal-title":"Drug Des Devel Ther"},{"key":"2043_CR29","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/ph17030368","volume":"17","author":"C Xiao","year":"2024","unstructured":"Xiao C, Hu W, Zhang Z, et al. Efficacy analysis and prognostic impact of Sivelestat sodium in coronavirus disease 2019-Related acute respiratory distress syndrome. Pharmaceuticals (Basel Switzerland). 2024;17:368. https:\/\/doi.org\/10.3390\/ph17030368.","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"key":"2043_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13019-024-02835-3","volume":"19","author":"H Lv","year":"2024","unstructured":"Lv H, Huang L, Yang X, et al. The clinical effectiveness of Sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy. J Cardiothorac Surg. 2024;19:399. https:\/\/doi.org\/10.1186\/s13019-024-02835-3.","journal-title":"J Cardiothorac Surg"},{"key":"2043_CR31","doi-asserted-by":"publisher","first-page":"104002","DOI":"10.1016\/j.resp.2022.104002","volume":"309","author":"GV Haute","year":"2023","unstructured":"Haute GV, Luft C, Pedrazza L, et al. Simvastatin attenuates inflammatory process on LPS-induced acute lung injury in mice. Respir Physiol Neurobiol. 2023;309:104002. https:\/\/doi.org\/10.1016\/j.resp.2022.104002.","journal-title":"Respir Physiol Neurobiol"},{"key":"2043_CR32","doi-asserted-by":"publisher","first-page":"L1026","DOI":"10.1152\/ajplung.00354.2004","volume":"288","author":"JR Jacobson","year":"2005","unstructured":"Jacobson JR, Barnard JW, Grigoryev DN, et al. Simvastatin attenuates vascular leak and inflammation in murine inflammatory lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;288:L1026\u20131032. https:\/\/doi.org\/10.1152\/ajplung.00354.2004.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2043_CR33","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1164\/rccm.200406-729OC","volume":"171","author":"MB Fessler","year":"2005","unstructured":"Fessler MB, Young SK, Jeyaseelan S, et al. A role for hydroxy-methylglutaryl coenzyme a reductase in pulmonary inflammation and host defense. Am J Respir Crit Care Med. 2005;171:606\u201315. https:\/\/doi.org\/10.1164\/rccm.200406-729OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2043_CR34","doi-asserted-by":"publisher","unstructured":"Kim Jw R, Ck K, Tj, et al. Effect of Pravastatin on bleomycin-induced acute lung injury and pulmonary fibrosis. Clin Exp Pharmacol Physiol. 2010;37. https:\/\/doi.org\/10.1111\/j.1440-1681.2010.05431.x.","DOI":"10.1111\/j.1440-1681.2010.05431.x"},{"key":"2043_CR35","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.3390\/ijms23052596","volume":"23","author":"L Lana Ne\u017ei\u0107","year":"2022","unstructured":"Lana Ne\u017ei\u0107 L, Amid\u017ei\u0107 R, \u0160krbi\u0107, et al. Amelioration of Endotoxin-Induced acute lung injury and alveolar epithelial cells apoptosis by Simvastatin is associated with Up-Regulation of Survivin\/NF-kB\/p65 pathway. Int J Mol Sci. 2022;23:2596. https:\/\/doi.org\/10.3390\/ijms23052596.","journal-title":"Int J Mol Sci"},{"key":"2043_CR36","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1164\/rccm.200810-1584OC","volume":"179","author":"TW Murali Shyamsundar, Scott","year":"2009","unstructured":"Murali Shyamsundar, Scott TW, McKeown, Cecilia M, O\u2019Kane, et al. Simvastatin decreases Lipopolysaccharide-induced pulmonary inflammation in healthy volunteers. Am J Respir Crit Care Med. 2009;179:1107\u201314. https:\/\/doi.org\/10.1164\/rccm.200810-1584OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2043_CR37","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1164\/rccm.201003-0423OC","volume":"183","author":"R Thelma","year":"2011","unstructured":"Thelma R, Craig MJ, Duffy M, Shyamsundar, et al. A randomized clinical trial of hydroxymethylglutaryl- coenzyme a reductase Inhibition for acute lung injury (The HARP Study). Am J Respir Crit Care Med. 2011;183:620\u20136. https:\/\/doi.org\/10.1164\/rccm.201003-0423OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2043_CR38","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1056\/NEJMoa2309995","volume":"389","author":"REMAP-CAP Investigators","year":"2023","unstructured":"Investigators REMAP-CAP, Hills TE, Lorenzi E, et al. Simvastatin in critically ill patients with Covid-19. N Engl J Med. 2023;389:2341\u201354. https:\/\/doi.org\/10.1056\/NEJMoa2309995.","journal-title":"N Engl J Med"},{"key":"2043_CR39","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000362724","volume":"22","author":"DC-TJA Cidlowski","year":"2015","unstructured":"Cidlowski DC-TJA. One hormone, two actions: anti- and pro-inflammatory effects of glucocorticoids. Neuroimmunomodulation. 2015;22:20\u201332. https:\/\/doi.org\/10.1159\/000362724.","journal-title":"Neuroimmunomodulation"},{"key":"2043_CR40","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2013.09.007","volume":"132","author":"H Robert","year":"2013","unstructured":"Robert H, Oakley JA, Cidlowski. The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease. J Allergy Clin Immunol. 2013;132:1033\u201344. https:\/\/doi.org\/10.1016\/j.jaci.2013.09.007.","journal-title":"J Allergy Clin Immunol"},{"key":"2043_CR41","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s11010-017-3166-y","volume":"440","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Xiong R-P, Chen X, et al. Hsp90 regulation affects the treatment of glucocorticoid for pancreatitis-induced lung injury. Mol Cell Biochem. 2018;440:189\u201397. https:\/\/doi.org\/10.1007\/s11010-017-3166-y.","journal-title":"Mol Cell Biochem"},{"key":"2043_CR42","doi-asserted-by":"publisher","first-page":"12138","DOI":"10.3390\/ijms241512138","volume":"24","author":"J Zhang","year":"2023","unstructured":"Zhang J, Ge P, Liu J, et al. Glucocorticoid treatment in acute respiratory distress syndrome: an overview on mechanistic insights and clinical benefit. Int J Mol Sci. 2023;24:12138. https:\/\/doi.org\/10.3390\/ijms241512138.","journal-title":"Int J Mol Sci"},{"key":"2043_CR43","doi-asserted-by":"publisher","unstructured":"Feng L-H, Li X-D, Zhang X-Y, et al. Dexamethasone for the treatment of acute respiratory distress syndrome: A systematic review and meta-analysis. Med (Baltim). 2022;101e30195. https:\/\/doi.org\/10.1097\/MD.0000000000030195.","DOI":"10.1097\/MD.0000000000030195"},{"key":"2043_CR44","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1007\/s00134-020-06289-8","volume":"46","author":"GU Meduri","year":"2020","unstructured":"Meduri GU, Annane D, Confalonieri M, et al. Pharmacological principles guiding prolonged glucocorticoid treatment in ARDS. Intensive Care Med. 2020;46:2284\u201396. https:\/\/doi.org\/10.1007\/s00134-020-06289-8.","journal-title":"Intensive Care Med"},{"key":"2043_CR45","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00540-021-03016-5","volume":"36","author":"T Shodai Yoshihiro","year":"2022","unstructured":"Shodai Yoshihiro T, Hongo S, Ohki, et al. Steroid treatment in patients with acute respiratory distress syndrome: a systematic review and network meta-analysis. J Anesth. 2022;36:107\u201321. https:\/\/doi.org\/10.1007\/s00540-021-03016-5.","journal-title":"J Anesth"},{"key":"2043_CR46","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1097\/CCM.0000000000002737","volume":"45","author":"SM Djillali Annane","year":"2017","unstructured":"Djillali Annane SM, Pastores B, Rochwerg, et al. Guidelines for the diagnosis and management of critical illness-Related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): society of critical care medicine (SCCM) and European society of intensive care medicine (ESICM) 2017. Crit Care Med. 2017;45:2078\u201388. https:\/\/doi.org\/10.1097\/CCM.0000000000002737.","journal-title":"Crit Care Med"},{"key":"2043_CR47","doi-asserted-by":"publisher","first-page":"e219","DOI":"10.1097\/CCM.0000000000006172","volume":"52","author":"AM Dipayan Chaudhuri","year":"2024","unstructured":"Dipayan Chaudhuri AM, Nei B, Rochwerg, et al. 2024 Focused update: guidelines on use of corticosteroids in sepsis, acute respiratory distress syndrome, and Community-Acquired pneumonia. Crit Care Med. 2024;52:e219\u201333. https:\/\/doi.org\/10.1097\/CCM.0000000000006172.","journal-title":"Crit Care Med"},{"key":"2043_CR48","doi-asserted-by":"publisher","first-page":"e004587","DOI":"10.1136\/bmjopen-2013-004587","volume":"4","author":"T Sigrid Narum","year":"2014","unstructured":"Sigrid Narum T, Westergren M Klemp. Corticosteroids and risk of Gastrointestinal bleeding: a systematic review and meta-analysis. BMJ Open. 2014;4:e004587. https:\/\/doi.org\/10.1136\/bmjopen-2013-004587.","journal-title":"BMJ Open"},{"key":"2043_CR49","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1136\/annrheumdis-2015-208916","volume":"75","author":"JWJ Cindy Strehl","year":"2016","unstructured":"Cindy Strehl JWJ, Bijlsma M, de Wit, et al. Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force. Ann Rheum Dis. 2016;75:952\u20137. https:\/\/doi.org\/10.1136\/annrheumdis-2015-208916.","journal-title":"Ann Rheum Dis"},{"key":"2043_CR50","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/cells10112921","volume":"10","author":"D Sybille","year":"2021","unstructured":"Sybille D, Reichardt A, Amouret C, Muzzi, et al. The role of glucocorticoids in inflammatory diseases. Cells. 2021;10:2921. https:\/\/doi.org\/10.3390\/cells10112921.","journal-title":"Cells"},{"key":"2043_CR51","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s13054-020-03164-2","volume":"24","author":"St\u00e9phane Romain Courcelle","year":"2020","unstructured":"Romain Courcelle St\u00e9phane, Gaudry N, Serck, et al. Neuromuscular blocking agents (NMBA) for COVID-19 acute respiratory distress syndrome: a multicenter observational study. Crit Care. 2020;24:446. https:\/\/doi.org\/10.1186\/s13054-020-03164-2.","journal-title":"Crit Care"},{"key":"2043_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bja.2022.08.009","volume":"130","author":"JA Jeevendra Martyn","year":"2023","unstructured":"Jeevendra Martyn JA, Sparling JL, Edward A, Bittner. Molecular mechanisms of muscular and non-muscular actions of neuromuscular blocking agents in critical illness: a narrative review. Br J Anaesth. 2023;130:39\u201350. https:\/\/doi.org\/10.1016\/j.bja.2022.08.009.","journal-title":"Br J Anaesth"},{"key":"2043_CR53","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s00134-020-06297-8","volume":"46","author":"T Sami Hraiech","year":"2020","unstructured":"Sami Hraiech T, Yoshida D, Annane, et al. Myorelaxants in ARDS patients. Intensive Care Med. 2020;46:2357\u201372. https:\/\/doi.org\/10.1007\/s00134-020-06297-8.","journal-title":"Intensive Care Med"},{"key":"2043_CR54","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/antiox13010095","volume":"13","author":"A Alpha","year":"2024","unstructured":"Alpha A, Fowler. Vitamin C: rationale for its use in Sepsis-Induced acute respiratory distress syndrome (ARDS). Antioxid (Basel Switzerland). 2024;13:95. https:\/\/doi.org\/10.3390\/antiox13010095.","journal-title":"Antioxid (Basel Switzerland)"},{"key":"2043_CR55","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/0003-4819-140-7-200404060-00010","volume":"140","author":"J Sebastian","year":"2004","unstructured":"Sebastian J, Padayatty H Sun, Yaohui Wang, et al. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann Intern Med. 2004;140:533\u20137. https:\/\/doi.org\/10.7326\/0003-4819-140-7-200404060-00010.","journal-title":"Ann Intern Med"},{"key":"2043_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13054-017-1891-y","volume":"21","author":"C Anitra","year":"2017","unstructured":"Anitra C, Carr PC, Rosengrave S, Bayer, et al. Hypovitaminosis C and vitamin C deficiency in critically ill patients despite recommended enteral and parenteral intakes. Crit Care (London England). 2017;21:300. https:\/\/doi.org\/10.1186\/s13054-017-1891-y.","journal-title":"Crit Care (London England)"},{"key":"2043_CR57","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00003246-199603000-00006","volume":"24","author":"E Borrelli","year":"1996","unstructured":"Borrelli E, Roux-Lombard P, Grau GE, et al. Plasma concentrations of cytokines, their soluble receptors, and antioxidant vitamins can predict the development of multiple organ failure in patients at risk. Crit Care Med. 1996;24:392\u20137. https:\/\/doi.org\/10.1097\/00003246-199603000-00006.","journal-title":"Crit Care Med"},{"key":"2043_CR58","doi-asserted-by":"publisher","unstructured":"Kristine Koekkoek WAC, Arthur RH, van Zanten. (2016) Antioxidant vitamins and trace elements in critical illness. nutrition in clinical practice: official publication of the American society for parenteral and enteral nutrition 31:457\u201374. https:\/\/doi.org\/10.1177\/0884533616653832","DOI":"10.1177\/0884533616653832"},{"key":"2043_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.pharmthera.2018.04.007","volume":"189","author":"E Paul","year":"2018","unstructured":"Paul E, Marik. Vitamin C for the treatment of sepsis: the scientific rationale. Pharmacol Ther. 2018;189:63\u201370. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.04.007.","journal-title":"Pharmacol Ther"},{"key":"2043_CR60","doi-asserted-by":"publisher","unstructured":"May Jm H Fe. Role of vitamin C in the function of the vascular endothelium. Antioxid Redox Signal. 2013;19. https:\/\/doi.org\/10.1089\/ars.2013.5205.","DOI":"10.1089\/ars.2013.5205"},{"key":"2043_CR61","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.3390\/nu12113286","volume":"12","author":"C Anitra","year":"2020","unstructured":"Anitra C, Carr S Rowe. The emerging role of vitamin C in the prevention and treatment of COVID-19. Nutrients. 2020;12:3286. https:\/\/doi.org\/10.3390\/nu12113286.","journal-title":"Nutrients"},{"key":"2043_CR62","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nri3024","volume":"11","author":"MA Alberto Mantovani","year":"2011","unstructured":"Alberto Mantovani MA, Cassatella C, Costantini, S\u00e9bastien Jaillon. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol. 2011;11:519\u201331. https:\/\/doi.org\/10.1038\/nri3024.","journal-title":"Nat Rev Immunol"},{"key":"2043_CR63","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.virusres.2016.11.033","volume":"228","author":"JM Agraz-Cibrian","year":"2017","unstructured":"Agraz-Cibrian JM, Giraldo DM, Mary F-M, Silvio Urcuqui-Inchima. Understanding the molecular mechanisms of NETs and their role in antiviral innate immunity. Virus Res. 2017;228:124\u201333. https:\/\/doi.org\/10.1016\/j.virusres.2016.11.033.","journal-title":"Virus Res"},{"key":"2043_CR64","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrmicro1710","volume":"5","author":"A Volker Brinkmann","year":"2007","unstructured":"Volker Brinkmann A Zychlinsky. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol. 2007;5:577\u201382. https:\/\/doi.org\/10.1038\/nrmicro1710.","journal-title":"Nat Rev Microbiol"},{"key":"2043_CR65","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3390\/ijms25031464","volume":"25","author":"J Xinyu Zhou","year":"2024","unstructured":"Xinyu Zhou J, Jin T, Lv Y, Song. A narrative review: the role of NETs in acute respiratory distress syndrome\/acute lung injury. Int J Mol Sci. 2024;25:1464. https:\/\/doi.org\/10.3390\/ijms25031464.","journal-title":"Int J Mol Sci"},{"key":"2043_CR66","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nm.4294","volume":"23","author":"K Selina","year":"2017","unstructured":"Selina K, Jorch PK. An emerging role for neutrophil extracellular traps in noninfectious disease. Nat Med. 2017;23:279\u201387. https:\/\/doi.org\/10.1038\/nm.4294.","journal-title":"Nat Med"},{"key":"2043_CR67","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/13543784.2023.2263366","volume":"32","author":"MG Matera","year":"2023","unstructured":"Matera MG, Rogliani P, Ora J, et al. A comprehensive overview of investigational elastase inhibitors for the treatment of acute respiratory distress syndrome. Expert Opin Invest Drugs. 2023;32:793\u2013802. https:\/\/doi.org\/10.1080\/13543784.2023.2263366.","journal-title":"Expert Opin Invest Drugs"},{"key":"2043_CR68","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1016\/j.burns.2012.08.005","volume":"39","author":"Jian-hua Jia-ke Chai","year":"2013","unstructured":"Jia-ke Chai Jian-hua, Cai Hu-ping, Deng, et al. Role of neutrophil elastase in lung injury induced by burn-blast combined injury in rats. Burns: J Int Soc Burn Injuries. 2013;39:745\u201353. https:\/\/doi.org\/10.1016\/j.burns.2012.08.005.","journal-title":"Burns: J Int Soc Burn Injuries"},{"key":"2043_CR69","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.ejphar.2004.01.037","volume":"488","author":"S Tetsuya Hagio","year":"2004","unstructured":"Tetsuya Hagio S, Matsumoto S, Nakao, et al. Elastase Inhibition reduced death associated with acid aspiration-induced lung injury in hamsters. Eur J Pharmacol. 2004;488:173\u201380. https:\/\/doi.org\/10.1016\/j.ejphar.2004.01.037.","journal-title":"Eur J Pharmacol"},{"key":"2043_CR70","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1111\/resp.12969","volume":"22","author":"K Takashi Kido","year":"2017","unstructured":"Takashi Kido K, Muramatsu K, Yatera, et al. Efficacy of early Sivelestat administration on acute lung injury and acute respiratory distress syndrome. Respirol (Carlton Vic). 2017;22:708\u201313. https:\/\/doi.org\/10.1111\/resp.12969.","journal-title":"Respirol (Carlton Vic)"},{"key":"2043_CR71","doi-asserted-by":"publisher","first-page":"106723","DOI":"10.1016\/j.ejps.2024.106723","volume":"195","author":"K Li","year":"2024","unstructured":"Li K, Dong L, Gao S, et al. Safety, tolerability, pharmacokinetics and neutrophil elastase inhibitory effects of Sivelestat: A randomized, double-blind, placebo-controlled single- and multiple-dose escalation study in Chinese healthy subjects. Eur J Pharm Sciences: Official J Eur Federation Pharm Sci. 2024;195:106723. https:\/\/doi.org\/10.1016\/j.ejps.2024.106723.","journal-title":"Eur J Pharm Sciences: Official J Eur Federation Pharm Sci"},{"key":"2043_CR72","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12890-017-0498-z","volume":"17","author":"D Shenglan Pu","year":"2017","unstructured":"Shenglan Pu D, Wang D, Liu, et al. Effect of Sivelestat sodium in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. BMC Pulm Med. 2017;17:148. https:\/\/doi.org\/10.1186\/s12890-017-0498-z.","journal-title":"BMC Pulm Med"},{"key":"2043_CR73","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1097\/HCO.0b013e3283398e53","volume":"25","author":"Petter Quist-Paulsen","year":"2010","unstructured":"Petter Quist-Paulsen. Statins and inflammation: an update. Curr Opin Cardiol. 2010;25:399\u2013405. https:\/\/doi.org\/10.1097\/HCO.0b013e3283398e53.","journal-title":"Curr Opin Cardiol"},{"key":"2043_CR74","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","volume":"28","author":"J Greenwood","year":"2007","unstructured":"Greenwood J, Justin C, Mason. Statins and the vascular endothelial inflammatory response. Trends Immunol. 2007;28:88\u201398. https:\/\/doi.org\/10.1016\/j.it.2006.12.003.","journal-title":"Trends Immunol"},{"key":"2043_CR75","doi-asserted-by":"publisher","unstructured":"O\u2019Neal Hr, Koyama T, Koehler E, et al. Prehospital Statin and aspirin use and the prevalence of severe sepsis and acute lung injury\/acute respiratory distress syndrome. Crit Care Med. 2011;39. https:\/\/doi.org\/10.1097\/CCM.0b013e3182120992.","DOI":"10.1097\/CCM.0b013e3182120992"},{"key":"2043_CR76","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","volume":"370","author":"JD Truwit","year":"2014","unstructured":"National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, Truwit JD, Bernard GR, et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med. 2014;370:2191\u2013200. https:\/\/doi.org\/10.1056\/NEJMoa1401520.","journal-title":"N Engl J Med"},{"key":"2043_CR77","doi-asserted-by":"publisher","first-page":"20750","DOI":"10.1038\/s41598-020-77448-6","volume":"10","author":"J Lanzhi Zheng","year":"2020","unstructured":"Lanzhi Zheng J, Su Z, Zhang, et al. Salidroside regulates inflammatory pathway of alveolar macrophages by influencing the secretion of miRNA-146a exosomes by lung epithelial cells. Sci Rep. 2020;10:20750. https:\/\/doi.org\/10.1038\/s41598-020-77448-6.","journal-title":"Sci Rep"},{"key":"2043_CR78","doi-asserted-by":"publisher","first-page":"12026","DOI":"10.1038\/s41598-017-12285-8","volume":"7","author":"K-C Lan","year":"2017","unstructured":"Lan K-C, Chao S-C, Wu H-Y, et al. Salidroside ameliorates sepsis-induced acute lung injury and mortality via downregulating NF-\u03baB and HMGB1 pathways through the upregulation of SIRT1. Sci Rep. 2017;7:12026. https:\/\/doi.org\/10.1038\/s41598-017-12285-8.","journal-title":"Sci Rep"},{"key":"2043_CR79","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.intimp.2016.04.004","volume":"35","author":"S Zhilin Qi","year":"2016","unstructured":"Zhilin Qi S, Qi L, Ling, et al. Salidroside attenuates inflammatory response via suppressing JAK2-STAT3 pathway activation and preventing STAT3 transfer into nucleus. Int Immunopharmacol. 2016;35:265\u201371. https:\/\/doi.org\/10.1016\/j.intimp.2016.04.004.","journal-title":"Int Immunopharmacol"},{"key":"2043_CR80","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.cyto.2018.03.042","volume":"110","author":"TU Soya Rungsung","year":"2018","unstructured":"Soya Rungsung TU, Singh DJ, Rabha, et al. Luteolin attenuates acute lung injury in experimental mouse model of sepsis. Cytokine. 2018;110:333\u201343. https:\/\/doi.org\/10.1016\/j.cyto.2018.03.042.","journal-title":"Cytokine"},{"key":"2043_CR81","doi-asserted-by":"publisher","first-page":"107600","DOI":"10.1016\/j.intimp.2021.107600","volume":"96","author":"Y Yang Wang","year":"2021","unstructured":"Yang Wang Y, Wang N, Cai, et al. Anti-inflammatory effects of Curcumin in acute lung injury: in vivo and in vitro experimental model studies. Int Immunopharmacol. 2021;96:107600. https:\/\/doi.org\/10.1016\/j.intimp.2021.107600.","journal-title":"Int Immunopharmacol"},{"key":"2043_CR82","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/ptr.6206","volume":"33","author":"Y Liang","year":"2019","unstructured":"Liang Y, Chongxi Fan, Xiaolong Yan, et al. Berberine ameliorates lipopolysaccharide-induced acute lung injury via the PERK-mediated Nrf2\/HO-1 signaling axis. Phytother Res. 2019;33:130\u201348. https:\/\/doi.org\/10.1002\/ptr.6206.","journal-title":"Phytother Res"},{"key":"2043_CR83","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s10753-021-01581-1","volume":"45","author":"L Yuhan Liu","year":"2022","unstructured":"Yuhan Liu L, Shang J, Zhou, et al. Emodin attenuates LPS-Induced acute lung injury by inhibiting NLRP3 inflammasome-Dependent pyroptosis signaling pathway in vitro and in vivo. Inflammation. 2022;45:753\u201367. https:\/\/doi.org\/10.1007\/s10753-021-01581-1.","journal-title":"Inflammation"},{"key":"2043_CR84","doi-asserted-by":"publisher","first-page":"108944","DOI":"10.1016\/j.intimp.2022.108944","volume":"110","author":"H Guo","year":"2022","unstructured":"Guo H, Song Y, Li F, et al. ACT001 suppressing M1 polarization against inflammation via NF-\u03baB and STAT1 signaling pathways alleviates acute lung injury in mice. Int Immunopharmacol. 2022;110:108944. https:\/\/doi.org\/10.1016\/j.intimp.2022.108944.","journal-title":"Int Immunopharmacol"},{"key":"2043_CR85","unstructured":"Dual targets guided screening. and isolation of Kukoamine B as a novel natural anti-sepsis agent from traditional Chinese herb Cortex lycii - PubMed. https:\/\/pubmed.ncbi.nlm.nih.gov\/21073991\/. Accessed 10 Nov 2024."},{"key":"2043_CR86","doi-asserted-by":"publisher","first-page":"154294","DOI":"10.1016\/j.jcrc.2023.154294","volume":"76","author":"X-YHW Zhang","year":"2023","unstructured":"Zhang X-YHW, Wang D, et al. Safety, tolerability, pharmacokinetics, and efficacy of Kukoamine B in patients with sepsis: A randomized phase IIa trial. J Crit Care. 2023;76:154294. https:\/\/doi.org\/10.1016\/j.jcrc.2023.154294.","journal-title":"J Crit Care"},{"key":"2043_CR87","doi-asserted-by":"publisher","first-page":"1054176","DOI":"10.3389\/fphar.2022.1054176","volume":"13","author":"T Shang","year":"2022","unstructured":"Shang T, Zhang Z-S, Wang X-T, et al. Xuebijing injection inhibited neutrophil extracellular traps to reverse lung injury in sepsis mice via reducing gasdermin D. Front Pharmacol. 2022;13:1054176. https:\/\/doi.org\/10.3389\/fphar.2022.1054176.","journal-title":"Front Pharmacol"},{"key":"2043_CR88","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jamainternmed.2023.0780","volume":"183","author":"C Songqiao Liu","year":"2023","unstructured":"Songqiao Liu C, Yao J, Xie, et al. Effect of an Herbal-Based injection on 28-Day mortality in patients with sepsis: the EXIT-SEP randomized clinical trial. JAMA Intern Med. 2023;183:647\u201355. https:\/\/doi.org\/10.1001\/jamainternmed.2023.0780.","journal-title":"JAMA Intern Med"},{"key":"2043_CR89","doi-asserted-by":"publisher","first-page":"820718","DOI":"10.3389\/fimmu.2022.820718","volume":"13","author":"H Chunling","year":"2022","unstructured":"Chunling H, Li J, Tan Y, et al. Tanreqing injection attenuates macrophage activation and the inflammatory response via the lncRNA-SNHG1\/HMGB1 Axis in Lipopolysaccharide-Induced acute lung injury. Front Immunol. 2022;13:820718. https:\/\/doi.org\/10.3389\/fimmu.2022.820718.","journal-title":"Front Immunol"},{"key":"2043_CR90","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3969\/j.issn.1008-9691.2018.03.005","volume":"25","author":"L Guo","year":"2018","unstructured":"Guo L, Guo S, Xu Z, et al. Effect of Tanreqing injection on levels of inflammatory mediators in patients with acute lung injury. Chin J Integr Tradit West Med Intensive Crit Care. 2018;25:242\u2013245. https:\/\/doi.org\/10.3969\/j.issn.1008-9691.2018.03.005","journal-title":"Chin J Integr Tradit West Med Intensive Crit Care"},{"key":"2043_CR91","doi-asserted-by":"publisher","first-page":"115763","DOI":"10.1016\/j.jep.2022.115763","volume":"301","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Han Q, Wang L, et al. Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and Inhibition of TLR4\/MyD88\/NF-\u03baB pathway. J Ethnopharmacol. 2023;301:115763. https:\/\/doi.org\/10.1016\/j.jep.2022.115763.","journal-title":"J Ethnopharmacol"},{"key":"2043_CR92","doi-asserted-by":"publisher","first-page":"154545","DOI":"10.1016\/j.phymed.2022.154545","volume":"108","author":"Z Li","year":"2023","unstructured":"Li Z, Pan H, Yang J, et al. Xuanfei Baidu formula alleviates impaired mitochondrial dynamics and activated NLRP3 inflammasome by repressing NF-\u03baB and MAPK pathways in LPS-induced ALI and inflammation models. Phytomedicine: Int J Phytotherapy Phytopharmacology. 2023;108:154545. https:\/\/doi.org\/10.1016\/j.phymed.2022.154545.","journal-title":"Phytomedicine: Int J Phytotherapy Phytopharmacology"},{"key":"2043_CR93","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1142\/S0192415X20500640","volume":"48","author":"F Tian-Tian","year":"2020","unstructured":"Tian-Tian F, Cheng B-L, Fang X-M, et al. Application of Chinese medicine in the management of critical conditions: A review on Sepsis. Am J Chin Med. 2020;48:1315\u201330. https:\/\/doi.org\/10.1142\/S0192415X20500640.","journal-title":"Am J Chin Med"},{"key":"2043_CR94","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.fct.2011.07.012","volume":"49","author":"M-Y Kuo","year":"2011","unstructured":"Kuo M-Y, Liao M-F, Chen F-L, et al. Luteolin attenuates the pulmonary inflammatory response involves abilities of antioxidation and Inhibition of MAPK and NF\u03baB pathways in mice with endotoxin-induced acute lung injury. Food Chem Toxicology: Int J Published Br Industrial Biol Res Association. 2011;49:2660\u20136. https:\/\/doi.org\/10.1016\/j.fct.2011.07.012.","journal-title":"Food Chem Toxicology: Int J Published Br Industrial Biol Res Association"},{"key":"2043_CR95","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/aps.2010.62","volume":"31","author":"Jen-pei Lee","year":"2010","unstructured":"Lee Jen-pei, Li Yi-ching, Chen Hung-yi, et al. Protective effects of Luteolin against lipopolysaccharide-induced acute lung injury involves Inhibition of MEK\/ERK and PI3K\/Akt pathways in neutrophils. Acta Pharmacol Sin. 2010;31:831\u20138. https:\/\/doi.org\/10.1038\/aps.2010.62.","journal-title":"Acta Pharmacol Sin"},{"key":"2043_CR96","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.biopha.2018.07.094","volume":"106","author":"J Xiuxia Liu","year":"2018","unstructured":"Xiuxia Liu J Meng. Luteolin alleviates LPS-induced Bronchopneumonia injury in vitro and in vivo by down-regulating microRNA-132 expression. Biomed Pharmacotherapy = Biomedecine Pharmacotherapie. 2018;106:1641\u20139. https:\/\/doi.org\/10.1016\/j.biopha.2018.07.094.","journal-title":"Biomed Pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"2043_CR97","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.12659\/msm.908714","volume":"24","author":"A Keping Cheng","year":"2018","unstructured":"Keping Cheng A, Yang X Hu, et al. Curcumin attenuates pulmonary inflammation in lipopolysaccharide induced acute lung injury in neonatal rat model by activating peroxisome Proliferator-Activated receptor \u03b3 (PPAR\u03b3) pathway. Med Sci Monitor: Int Med J Experimental Clin Res. 2018;24:1178\u201384. https:\/\/doi.org\/10.12659\/msm.908714.","journal-title":"Med Sci Monitor: Int Med J Experimental Clin Res"},{"key":"2043_CR98","doi-asserted-by":"publisher","first-page":"13294","DOI":"10.1096\/fj.201901047RR","volume":"33","author":"B Zhang","year":"2019","unstructured":"Zhang B, Swamy S, Balijepalli S, et al. Direct pulmonary delivery of solubilized Curcumin reduces severity of lethal pneumonia. Faseb J. 2019;33:13294\u2013309. https:\/\/doi.org\/10.1096\/fj.201901047RR.","journal-title":"Faseb J"},{"key":"2043_CR99","doi-asserted-by":"publisher","first-page":"109946","DOI":"10.1016\/j.biopha.2020.109946","volume":"125","author":"Y-S Chai","year":"2020","unstructured":"Chai Y-S, Chen Y-Q, Lin S-H, et al. Curcumin regulates the differentiation of Na\u00efve CD4\u2009+\u2009T cells and activates IL-10 immune modulation against acute lung injury in mice. Biomedecine Pharmacotherapie. 2020;125:109946. https:\/\/doi.org\/10.1016\/j.biopha.2020.109946.","journal-title":"Biomedecine Pharmacotherapie"},{"key":"2043_CR100","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/SHK.0b013e318157ea14","volume":"29","author":"Hao-qing Zhang","year":"2008","unstructured":"Zhang Hao-qing, Wang Hua-dong, Lu Da-xiang, et al. Berberine inhibits cytosolic phospholipase A2 and protects against LPS-induced lung injury and lethality independent of the alpha2-adrenergic receptor in mice. Shock. 2008;29:617\u201322. https:\/\/doi.org\/10.1097\/SHK.0b013e318157ea14.","journal-title":"Shock"},{"key":"2043_CR101","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2147\/DDDT.S401293","volume":"17","author":"L Chen","year":"2023","unstructured":"Chen L, Liu X, Wang X, et al. Berberine alleviates acute lung injury in septic mice by modulating Treg\/Th17 homeostasis and downregulating NF-\u03baB signaling. Drug Des Dev Ther Volume. 2023;17:1139\u201351. https:\/\/doi.org\/10.2147\/DDDT.S401293.","journal-title":"Drug Des Dev Ther Volume"},{"key":"2043_CR102","doi-asserted-by":"publisher","first-page":"106626","DOI":"10.1016\/j.intimp.2020.106626","volume":"85","author":"R Guo","year":"2020","unstructured":"Guo R, Li Y, Han M, et al. Emodin attenuates acute lung injury in Cecal-ligation and puncture rats. Int Immunopharmacol. 2020;85:106626. https:\/\/doi.org\/10.1016\/j.intimp.2020.106626.","journal-title":"Int Immunopharmacol"},{"key":"2043_CR103","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1016\/j.apsb.2021.10.008","volume":"12","author":"H Qian","year":"2022","unstructured":"Qian H, Yao J, Wu X, et al. Emodin attenuates severe acute pancreatitis-associated acute lung injury by suppressing pancreatic exosome-mediated alveolar macrophage activation. Acta Pharm Sinica B. 2022;12:3986\u20134003. https:\/\/doi.org\/10.1016\/j.apsb.2021.10.008.","journal-title":"Acta Pharm Sinica B"},{"key":"2043_CR104","doi-asserted-by":"publisher","first-page":"5943","DOI":"10.7150\/thno.41498","volume":"10","author":"L Tong","year":"2020","unstructured":"Tong L, Li J, Li Q, et al. ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 2020;10:5943\u201356. https:\/\/doi.org\/10.7150\/thno.41498.","journal-title":"Theranostics"},{"key":"2043_CR105","doi-asserted-by":"publisher","first-page":"111471","DOI":"10.1016\/j.biopha.2021.111471","volume":"138","author":"I Jade Jaffar","year":"2021","unstructured":"Jade Jaffar I, Glaspole K, Symons G Westall. Inhibition of NF-\u03baB by ACT001 reduces fibroblast activity in idiopathic pulmonary fibrosis. Biomed Pharmacother. 2021;138:111471. https:\/\/doi.org\/10.1016\/j.biopha.2021.111471.","journal-title":"Biomed Pharmacother"},{"key":"2043_CR106","doi-asserted-by":"publisher","DOI":"10.1007\/s13258-023-01455-w","author":"Q Fu","year":"2023","unstructured":"Fu Q, Shen N, Tao Fang, et al. ACT001 alleviates inflammation and pyroptosis through the PPAR-\u03b3\/NF-\u03baB signaling pathway in LPS-induced alveolar macrophages. Genes Genom. 2023. https:\/\/doi.org\/10.1007\/s13258-023-01455-w.","journal-title":"Genes Genom"},{"key":"2043_CR107","doi-asserted-by":"publisher","first-page":"100195","DOI":"10.1016\/j.prmcm.2022.100195","volume":"5","author":"X Qiang Fu","year":"2022","unstructured":"Qiang Fu X, Liu N, Shen, et al. Administration of parthenolide extract (ACT001) improved autophagy and attenuate inflammatory in rats with ARDS. Pharmacol Res - Mod Chin Med. 2022;5:100195. https:\/\/doi.org\/10.1016\/j.prmcm.2022.100195.","journal-title":"Pharmacol Res - Mod Chin Med"},{"key":"2043_CR108","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1111\/j.1476-5381.2010.01114.x","volume":"162","author":"X Xin Liu","year":"2011","unstructured":"Xin Liu X, Zheng N, Wang, et al. Kukoamine B, a novel dual inhibitor of LPS and CpG DNA, is a potential candidate for sepsis treatment. Br J Pharmacol. 2011;162:1274\u201390. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01114.x.","journal-title":"Br J Pharmacol"},{"key":"2043_CR109","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/S1875-5364(23)60463-7","volume":"21","author":"C Zhang","year":"2023","unstructured":"Zhang C, Chen X, Wei T, et al. Xuebijing alleviates LPS-induced acute lung injury by downregulating pro-inflammatory cytokine production and inhibiting gasdermin-E-mediated pyroptosis of alveolar epithelial cells. Chin J Nat Med. 2023;21:576\u201388. https:\/\/doi.org\/10.1016\/S1875-5364(23)60463-7.","journal-title":"Chin J Nat Med"},{"key":"2043_CR110","doi-asserted-by":"publisher","first-page":"627751","DOI":"10.3389\/fphar.2021.627751","volume":"12","author":"J Guo","year":"2021","unstructured":"Guo J, Zhu J, Wang Q, et al. Comparative efficacy of seven kinds of Chinese medicine injections in acute lung injury and acute respiratory distress syndrome: A network Meta-analysis of randomized controlled trials. Front Pharmacol. 2021;12:627751. https:\/\/doi.org\/10.3389\/fphar.2021.627751.","journal-title":"Front Pharmacol"},{"key":"2043_CR111","doi-asserted-by":"publisher","first-page":"746964","DOI":"10.3389\/fphar.2021.746964","volume":"12","author":"Y-Q He","year":"2021","unstructured":"He Y-Q, Zhou C-C, Deng J-L, et al. Tanreqing inhibits LPS-Induced acute lung injury in vivo and in vitro through downregulating STING signaling pathway. Front Pharmacol. 2021;12:746964. https:\/\/doi.org\/10.3389\/fphar.2021.746964.","journal-title":"Front Pharmacol"},{"key":"2043_CR112","doi-asserted-by":"publisher","first-page":"104743","DOI":"10.1016\/j.phrs.2020.104743","volume":"155","author":"Jun-ling Ren","year":"2020","unstructured":"Ren Jun-ling, Zhang A-H, Wang X-J. Traditional Chinese medicine for COVID-19 treatment. Pharmacol Res. 2020;155:104743. https:\/\/doi.org\/10.1016\/j.phrs.2020.104743.","journal-title":"Pharmacol Res"},{"key":"2043_CR113","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.pharmthera.2021.107843","volume":"225","author":"K Huang","year":"2021","unstructured":"Huang K, Zhang P, Zhang Z, et al. Traditional Chinese medicine (TCM) in the treatment of COVID-19 and other viral infections: efficacies and mechanisms. Pharmacol Ther. 2021;225:107843. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107843.","journal-title":"Pharmacol Ther"},{"key":"2043_CR114","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11655-019-3078-7","volume":"26","author":"Y-B Chen","year":"2020","unstructured":"Chen Y-B, Liu Q, Xie H, et al. Is Chinese medicine injection applicable for treating acute lung injury and acute respiratory distress syndrome?? A systematic review and Meta-analysis of randomized controlled trials. Chin J Integr Med. 2020;26:857\u201366. https:\/\/doi.org\/10.1007\/s11655-019-3078-7.","journal-title":"Chin J Integr Med"},{"key":"2043_CR115","doi-asserted-by":"publisher","first-page":"8095","DOI":"10.2147\/IJN.S179380","volume":"13","author":"G Xiaohong Yang","year":"2018","unstructured":"Xiaohong Yang G, Shi J, Guo, et al. Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus. Int J Nanomed. 2018;13:8095\u2013104. https:\/\/doi.org\/10.2147\/IJN.S179380.","journal-title":"Int J Nanomed"},{"key":"2043_CR116","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1097\/JCMA.0000000000000189","volume":"82","author":"J-S Liu","year":"2019","unstructured":"Liu J-S, Du J, Cheng X, et al. Exosomal miR-451 from human umbilical cord mesenchymal stem cells attenuates burn-induced acute lung injury. J Chin Med Association: JCMA. 2019;82:895\u2013901. https:\/\/doi.org\/10.1097\/JCMA.0000000000000189.","journal-title":"J Chin Med Association: JCMA"},{"key":"2043_CR117","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41419-020-02857-4","volume":"11","author":"X Wei","year":"2020","unstructured":"Wei X, Yi X, Lv H, et al. MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy. Cell Death Dis. 2020;11:657. https:\/\/doi.org\/10.1038\/s41419-020-02857-4.","journal-title":"Cell Death Dis"},{"key":"2043_CR118","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/SHK.0000000000001549","volume":"54","author":"L Huimin Deng","year":"2020","unstructured":"Huimin Deng L, Wu M, Liu, et al. Bone marrow mesenchymal stem Cell-Derived exosomes attenuate LPS-Induced ARDS by modulating macrophage polarization through inhibiting Glycolysis in macrophages. Shock (Augusta Ga). 2020;54:828\u201343. https:\/\/doi.org\/10.1097\/SHK.0000000000001549.","journal-title":"Shock (Augusta Ga)"},{"key":"2043_CR119","doi-asserted-by":"publisher","unstructured":"Xuan Liu C, Gao Y, Wang et al. (2021) BMSC-Derived Exosomes Ameliorate LPS-Induced Acute Lung Injury by miR-384-5p-Controlled Alveolar Macrophage Autophagy. Oxid Med Cell Longev 2021:9973457. https:\/\/doi.org\/10.1155\/2021\/9973457","DOI":"10.1155\/2021\/9973457"},{"key":"2043_CR120","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/stem.1504","volume":"32","author":"Y-G Zhu","year":"2014","unstructured":"Zhu Y-G, Feng X-M, Abbott J, et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells. 2014;32:116\u201325. https:\/\/doi.org\/10.1002\/stem.1504.","journal-title":"Stem Cells"},{"key":"2043_CR121","doi-asserted-by":"publisher","first-page":"7837837","DOI":"10.1155\/2022\/7837837","volume":"2022","author":"L Huimin Deng","year":"2022","unstructured":"Huimin Deng L, Zhu Y, Zhang, et al. Differential lung protective capacity of exosomes derived from human adipose tissue, bone marrow, and umbilical cord mesenchymal stem cells in Sepsis-Induced acute lung injury. Oxid Med Cell Longev. 2022;2022:7837837. https:\/\/doi.org\/10.1155\/2022\/7837837.","journal-title":"Oxid Med Cell Longev"},{"key":"2043_CR122","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s10753-021-01548-2","volume":"45","author":"X Weijun Shen","year":"2022","unstructured":"Weijun Shen X, Zhao S, Li. Exosomes derived from ADSCs attenuate Sepsis-Induced lung injury by delivery of Circ-Fryl and regulation of the miR-490-3p\/SIRT3 pathway. Inflammation. 2022;45:331\u201342. https:\/\/doi.org\/10.1007\/s10753-021-01548-2.","journal-title":"Inflammation"},{"key":"2043_CR123","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41551-022-00902-5","volume":"6","author":"KD Zhenzhen Wang","year":"2022","unstructured":"Zhenzhen Wang KD, Popowski D, Zhu, et al. Exosomes decorated with a Recombinant SARS-CoV-2 receptor-binding domain as an inhalable COVID-19 vaccine. Nat Biomed Eng. 2022;6:791\u2013805. https:\/\/doi.org\/10.1038\/s41551-022-00902-5.","journal-title":"Nat Biomed Eng"},{"key":"2043_CR124","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.neuron.2020.07.015","volume":"108","author":"Z-F Shenbin Liu","year":"2020","unstructured":"Shenbin Liu Z-F, Wang Y-S, Su, et al. Somatotopic organization and intensity dependence in driving distinct NPY-Expressing sympathetic pathways by electroacupuncture. Neuron. 2020;108:436\u2013e4507. https:\/\/doi.org\/10.1016\/j.neuron.2020.07.015.","journal-title":"Neuron"},{"key":"2043_CR125","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10753-018-0944-y","volume":"42","author":"D Huang","year":"2019","unstructured":"Huang D, Chen M, Wang Z, et al. Electroacupuncture pretreatment attenuates inflammatory lung injury after cardiopulmonary bypass by suppressing NLRP3 inflammasome activation in rats. Inflammation. 2019;42:895\u2013903. https:\/\/doi.org\/10.1007\/s10753-018-0944-y.","journal-title":"Inflammation"},{"key":"2043_CR126","doi-asserted-by":"publisher","first-page":"832432","DOI":"10.3389\/fimmu.2022.832432","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zheng L, Deng H, et al. Electroacupuncture alleviates LPS-Induced ARDS through \u03917 nicotinic acetylcholine Receptor-Mediated Inhibition of ferroptosis. Front Immunol. 2022;13:832432. https:\/\/doi.org\/10.3389\/fimmu.2022.832432.","journal-title":"Front Immunol"},{"key":"2043_CR127","doi-asserted-by":"publisher","unstructured":"Ji H, Zhang C, Xu F et al. (2022) Inhaled Pro-Efferocytic Nanozymes Promote Resolution of Acute Lung Injury. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 9:. https:\/\/doi.org\/10.1002\/advs.202201696","DOI":"10.1002\/advs.202201696"},{"key":"2043_CR128","doi-asserted-by":"publisher","unstructured":"Huang W, Wen L, Tian H, et al, et al. Self-Propelled proteomotors with active Cell-Free MtDNA clearance for enhanced therapy of Sepsis-Associated acute lung injury. Adv Sci (Weinheim Baden-Wurttemberg Germany). 2023;10. https:\/\/doi.org\/10.1002\/advs.202301635.","DOI":"10.1002\/advs.202301635"},{"key":"2043_CR129","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1021\/acscentsci.1c00866","volume":"8","author":"R Yuan","year":"2022","unstructured":"Yuan R, Li Y, Han S, et al. Fe-Curcumin Nanozyme-Mediated reactive oxygen species scavenging and Anti-Inflammation for acute lung injury. ACS Cent Sci. 2022;8:10\u201321. https:\/\/doi.org\/10.1021\/acscentsci.1c00866.","journal-title":"ACS Cent Sci"},{"key":"2043_CR130","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s12951-024-02597-z","volume":"22","author":"X Guozhen Wang","year":"2024","unstructured":"Guozhen Wang X, Ma W, Huang, et al. Macrophage biomimetic nanoparticle-targeted functional extracellular vesicle micro-RNAs revealed via multiomics analysis alleviate sepsis-induced acute lung injury. J Nanobiotechnol. 2024;22:362. https:\/\/doi.org\/10.1186\/s12951-024-02597-z.","journal-title":"J Nanobiotechnol"},{"key":"2043_CR131","doi-asserted-by":"publisher","first-page":"8551","DOI":"10.1021\/acsnano.3c00906","volume":"17","author":"Z Li","year":"2023","unstructured":"Li Z, Feng Y, Zhang S, et al. A multifunctional nanoparticle mitigating cytokine storm by scavenging multiple inflammatory mediators of Sepsis. ACS Nano. 2023;17:8551\u201363. https:\/\/doi.org\/10.1021\/acsnano.3c00906.","journal-title":"ACS Nano"},{"key":"2043_CR132","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.bioactmat.2024.04.013","volume":"39","author":"X Yang Wu","year":"2024","unstructured":"Yang Wu X, Chen Z, Zeng, et al. Self-assembled carbon monoxide nanogenerators managing sepsis through scavenging multiple inflammatory mediators. Bioactive Mater. 2024;39:595\u2013611. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.04.013.","journal-title":"Bioactive Mater"},{"key":"2043_CR133","doi-asserted-by":"publisher","first-page":"176354","DOI":"10.1016\/j.ejphar.2024.176354","volume":"968","author":"X-Y Li","year":"2024","unstructured":"Li X-Y, Qiu C-M, Yang F-Y, et al. Protective effects of Prussian blue nanozyme against sepsis-induced acute lung injury by activating HO-1. Eur J Pharmacol. 2024;968:176354. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176354.","journal-title":"Eur J Pharmacol"},{"key":"2043_CR134","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/cphy.c200006","volume":"11","author":"J Yuansheng Gao","year":"2020","unstructured":"Yuansheng Gao J, Usha R. Extracellular vesicles as unique signaling messengers: role in lung diseases. Compr Physiol. 2020;11:1351\u201369. https:\/\/doi.org\/10.1002\/cphy.c200006.","journal-title":"Compr Physiol"},{"key":"2043_CR135","doi-asserted-by":"publisher","first-page":"35250","DOI":"10.1038\/srep35250","volume":"6","author":"H Lee","year":"2016","unstructured":"Lee H, Zhang D, Zhu Z, et al. Epithelial cell-derived microvesicles activate macrophages and promote inflammation via microvesicle-containing MicroRNAs. Sci Rep. 2016;6:35250. https:\/\/doi.org\/10.1038\/srep35250.","journal-title":"Sci Rep"},{"key":"2043_CR136","doi-asserted-by":"publisher","first-page":"6917","DOI":"10.2147\/IJN.S264498","volume":"15","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Bi J, Huang J, et al. Exosome: A review of its classification, isolation techniques, storage, diagnostic and targeted therapy applications. Int J Nanomed. 2020;15:6917\u201334. https:\/\/doi.org\/10.2147\/IJN.S264498.","journal-title":"Int J Nanomed"},{"key":"2043_CR137","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1093\/pcmedi\/pbaa007","volume":"3","author":"H Qian","year":"2020","unstructured":"Qian H, Su H, Li J, et al. Clinical applications of exosome membrane proteins. Precision Clin Med. 2020;3:54\u201366. https:\/\/doi.org\/10.1093\/pcmedi\/pbaa007.","journal-title":"Precision Clin Med"},{"key":"2043_CR138","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40779-022-00417-9","volume":"9","author":"H Qian","year":"2022","unstructured":"Qian H, Zhang S, Yang Y, et al. Extracellular vesicles in the pathogenesis and treatment of acute lung injury. Military Med Res. 2022;9:61. https:\/\/doi.org\/10.1186\/s40779-022-00417-9.","journal-title":"Military Med Res"},{"key":"2043_CR139","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41418-021-00841-9","volume":"29","author":"K Yang","year":"2022","unstructured":"Yang K, Wang MFX, et al. Lactate promotes macrophage HMGB1 lactylation, acetylation, and Exosomal release in polymicrobial sepsis. Cell Death Differ. 2022;29:133\u201346. https:\/\/doi.org\/10.1038\/s41418-021-00841-9.","journal-title":"Cell Death Differ"},{"key":"2043_CR140","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13054-021-03775-3","volume":"25","author":"J Yang","year":"2021","unstructured":"Yang J, Zhang T, Zhang C, et al. Exosomal miR-30d-5p of neutrophils induces M1 macrophage polarization and primes macrophage pyroptosis in sepsis-related acute lung injury. Crit Care. 2021;25:356. https:\/\/doi.org\/10.1186\/s13054-021-03775-3.","journal-title":"Crit Care"},{"key":"2043_CR141","doi-asserted-by":"publisher","first-page":"4718","DOI":"10.1096\/fj.201903089R","volume":"34","author":"JM Christina Draijer","year":"2020","unstructured":"Christina Draijer JM, Speth, Loka RK, Penke, et al. Resident alveolar macrophage-derived vesicular SOCS3 dampens allergic airway inflammation. FASEB J. 2020;34:4718\u201331. https:\/\/doi.org\/10.1096\/fj.201903089R.","journal-title":"FASEB J"},{"key":"2043_CR142","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1111\/trf.14838","volume":"59","author":"JH Lee","year":"2019","unstructured":"Lee JH, Park J, Lee J-W. Therapeutic use of mesenchymal stem cell-derived extracellular vesicles in acute lung injury. Transfusion. 2019;59:876\u201383. https:\/\/doi.org\/10.1111\/trf.14838.","journal-title":"Transfusion"},{"key":"2043_CR143","doi-asserted-by":"publisher","first-page":"761338","DOI":"10.3389\/fmicb.2021.761338","volume":"12","author":"J You","year":"2021","unstructured":"You J, Fu Z, Lin Zou. Mechanism and potential of extracellular vesicles derived from mesenchymal stem cells for the treatment of infectious diseases. Front Microbiol. 2021;12:761338. https:\/\/doi.org\/10.3389\/fmicb.2021.761338.","journal-title":"Front Microbiol"},{"key":"2043_CR144","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1517\/14712598.2016.1170804","volume":"16","author":"A Monsel","year":"2016","unstructured":"Monsel A, Zhu Y-G, Gudapati V, et al. Mesenchymal stem cell derived secretome and extracellular vesicles for acute lung injury and other inflammatory lung diseases. Expert Opin Biol Ther. 2016;16:859\u201371. https:\/\/doi.org\/10.1517\/14712598.2016.1170804.","journal-title":"Expert Opin Biol Ther"},{"key":"2043_CR145","doi-asserted-by":"publisher","first-page":"1003658","DOI":"10.3389\/fphar.2023.1003658","volume":"14","author":"W Yaqin Song","year":"2023","unstructured":"Yaqin Song W, Lin W, Zhu. Traditional Chinese medicine for treatment of sepsis and related multi-organ injury. Front Pharmacol. 2023;14:1003658. https:\/\/doi.org\/10.3389\/fphar.2023.1003658.","journal-title":"Front Pharmacol"},{"key":"2043_CR146","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.2147\/JIR.S312385","volume":"14","author":"OM Yao Zou","year":"2021","unstructured":"Yao Zou OM, Bhat X, Yuan, et al. Release and actions of inflammatory exosomes in pulmonary emphysema: potential therapeutic target of acupuncture. J Inflamm Res. 2021;14:3501\u201321. https:\/\/doi.org\/10.2147\/JIR.S312385.","journal-title":"J Inflamm Res"},{"key":"2043_CR147","doi-asserted-by":"publisher","first-page":"e2312169","DOI":"10.1002\/adma.202312169","volume":"36","author":"L Twan","year":"2024","unstructured":"Twan L. Nanomedicine tumor targeting. Advanced materials. (Deerfield Beach Fla). 2024;36:e2312169. https:\/\/doi.org\/10.1002\/adma.202312169.","journal-title":"(Deerfield Beach Fla)"},{"key":"2043_CR148","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.apsb.2019.08.003","volume":"9","author":"J Chong Li","year":"2019","unstructured":"Chong Li J, Wang Y, Wang, et al. Recent progress in drug delivery. Acta Pharm Sinica B. 2019;9:1145\u201362. https:\/\/doi.org\/10.1016\/j.apsb.2019.08.003.","journal-title":"Acta Pharm Sinica B"},{"key":"2043_CR149","doi-asserted-by":"publisher","first-page":"119428","DOI":"10.1016\/j.lfs.2021.119428","volume":"276","author":"S Pragya Prasanna","year":"2021","unstructured":"Pragya Prasanna S, Rathee A, Upadhyay S Sulakshana. Nanotherapeutics in the treatment of acute respiratory distress syndrome. Life Sci. 2021;276:119428. https:\/\/doi.org\/10.1016\/j.lfs.2021.119428.","journal-title":"Life Sci"},{"key":"2043_CR150","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.2147\/IJN.S300594","volume":"16","author":"H Shuai Bian","year":"2021","unstructured":"Shuai Bian H, Cai Y, Cui, et al. Nanomedicine-Based therapeutics to combat acute lung injury. Int J Nanomed. 2021;16:2247\u201369. https:\/\/doi.org\/10.2147\/IJN.S300594.","journal-title":"Int J Nanomed"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-025-02043-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-025-02043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T16:55:53Z","timestamp":1767200153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-025-02043-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2043"],"URL":"https:\/\/doi.org\/10.1007\/s00011-025-02043-2","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"14 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"74"}}